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ABNORMAL NEUROGENESIS AND GLIOGENESIS IN THE DEVELOPING 
SPINAL CORD IN A MOUSE MODEL OF DOWN SYNDROME 
MORGAN BRADY 
ABSTRACT 
 Motor deficits are a hallmark of Down syndrome (DS), yet little is known 
about their exact cause. Despite the rich understanding of the neurobiology of 
DS, there is still a lack of targetable mechanisms for early intervention aimed at 
alleviating motor changes in people with DS. Therefore, we utilized a mouse 
model of DS known as Ts65Dn to characterize for the first time the effects of 
trisomy 21 on spinal cord (SC) development. A central molecular player in SC 
patterning and cell-type specification, Oligodendrocyte transcription factor 2 
(Olig2), is located on human chromosome 21 (Hsa21) and is triplicated in both 
people with DS and in Ts65Dn mice. To observe the effects of the 
supernumerary Olig2, we used immunohistochemistry to visualize the OLIG2-
derived cellular populations (i.e., motor neurons (MNs) and oligodendrocytes 
(OLs)), as well as adjacent and interacting cell populations (i.e., ventral spinal 
interneurons (INs)). We limited our analyses to two embryonic ages—embryonic 
days (E) 12.5 and 14.5. Our results indicate that there is no overall change in the 
numbers of OLs at either E12.5 or E14.5. However, there tend to be more OL-
fated cells within the pMN domain, where they originate, and migrating cells tend 
to be clustered closer to the pMN domain at E12.5. IN populations show some 
changes in Ts65Dn mice at E12.5, with both total and abventricular PAX6+ cell 
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numbers and abventricular NKX2.2+ cell numbers increased in Ts65Dn embryos 
compared to euploid mice. However, at E14.5 the number of NKX2.2+ cells is 
unchanged. No difference in the NKX6.1+ population was seen at either time-
point. In contrast, there are significant changes in the MN population at both 
E12.5 and E14.5. Specifically, at E12.5, the total ISL1+ MN population is 
significantly increased and shows altered regional distribution in the ventral horn 
of Ts65Dn SCs. Conversely, the Ts65Dn spinal MN population is normalized to 
euploid levels at E14.5. Overall, our results suggest that neurogenesis, 
gliogenesis, and cell-type specification of OLIG2-lineage cells are altered in the 
developing SC of Ts65Dn mice. Thus, this work identifies a novel target for future 
therapeutic interventions aimed at ameliorating motor changes in DS.  
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INTRODUCTION 
 
 Down syndrome (DS) occurs at a frequency of approximately 1 in 792 live 
births in the United States and is caused by trisomy of human chromosome 21 
(Hsa21) (Lejeune et al., 1959; de Graaf et al., 2015) . DS is the most prevalent 
live-born autosomal aneuploidy and the most common genetic cause of 
intellectual disability and developmental delay (Yu et al., 2010; Mai et al., 2015; 
Olmos-Serrano et al., 2016). Individuals with DS display a wide range of motor 
and cognitive deficits with varying severity.  
Both pre- and postnatal brains from individuals with DS show reduced 
overall brain volume and a disproportionately reduced cerebellar volume 
(Aylward et al., 1997; Pinter et al., 2001; Guidi et al., 2011). These volume 
changes are due to hypoplasia of the cerebellum (Guidi et al., 2011), 
hippocampus (Sylvester, 1983; Guidi et al., 2008), and neocortex (Larsen et al., 
2008). In particular, cerebella in DS fetuses have fewer Purkinje and granule 
cells (Guidi et al., 2011) and the reduction in brain volume observed during 
gestation is maintained postnatally (Śmigielska-Kuzia et al., 2011). Frontal lobe, 
temporal lobe, hippocampus, amygdala, and cerebellum volumes are reduced in 
infants, children, and adults with DS (Pinter et al., 2001; Śmigielska-Kuzia et al., 
2011). In contrast, subcortical structures and parietal lobe gray matter volumes 
are preserved (Pinter et al., 2001).  
People with DS show impaired learning and memory, especially in verbal 
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short-term memory (Jarrold et al., 1999) and explicit memory (Vicari et al., 2000), 
which are thought to be rooted in the hippocampal hypotrophy (Pinter et al., 
2001; Guidi et al., 2008; Śmigielska-Kuzia et al., 2011). On the other hand, 
visuospatial short-term and implicit memory appear relatively unaffected (Jarrold 
et al., 1999; Vicari et al., 2000), likely due to the preserved parietal lobe gray 
matter (Jarrold et al., 1999; Pinter et al., 2001). In addition, reduced frontal lobe 
volume (Pinter et al., 2001) in individuals with DS likely underlies the executive 
function deficits that are highly penetrant in this population (Lanfranchi et al., 
2010).  
Motor deficits also accompany the cognitive changes in people with DS. 
Individuals with DS show developmental delays in acquiring both fine and gross 
motor skills (Costa et al., 1999). Infants and toddlers with DS show delayed 
achievement of motor milestones including grasping, rolling, sitting, standing, 
walking, and speaking (Melyn and White, 1973; Palisano et al., 2001; Rigoldi et 
al., 2011). Although delayed, these milestones are achieved in the same order in 
individuals with DS as in typically developing individuals (Palisano et al., 2001; 
Vicari, 2006), however the delays in milestone acquisition increase with age and 
in accordance with task complexity (Melyn and White, 1973; Pereira et al., 2013). 
Hypotonia, hyporeflexia, clumsiness (Costa et al., 1999), longer reaction and 
movement times (Henderson et al., 1981; Hampton et al., 2004), and co-
contraction of agonist and antagonist muscle pairs (Hampton et al., 2004) are 
also characteristic of DS. Throughout the lifespan, motor movements in 
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individuals with DS lack precision, are poorly coordinated, and are inefficient 
(Henderson et al., 1981). Infants with DS start walking later than their typically 
developing peers and exhibit altered gait that improves over time in response to 
physical therapy which enables them to compensate for ligament laxity and 
hypotonia (Rigoldi et al., 2011). Like locomotion, which relies on central pattern 
generators (CPGs) in the spinal cord (SC) (Brown, 1911; Marder and Bucher, 
2001), modulation of grip hinges on sensory afferents (Johansson and Westling, 
1987) and is therefore relatively independent from higher cortical areas (Cole et 
al., 1988). Cole et al. (1988) showed that individuals with DS use excessive force 
in grip production, have decreased control of grip strength, and an inability to 
adapt grip to environmental changes. Finally, postural control is impaired in 
individuals with DS (Rast and Harris, 1985).  
Notably, the success of motor development in infancy has been found to 
be associated with language development and cognitive abilities later in life (von 
Wendt et al., 1984; Taanila et al., 2005; Murray et al., 2006; Iverson, 2010). 
Therefore, a link between motor function and cognitive abilities may exist in 
individuals with DS. In general, the underlying cause of all these central nervous 
system and behavioral abnormalities is ultimately due to the triplication of Hsa21; 
however, the exact cellular mechanisms are largely unknown. Thus, pinpointing 
and correcting the underlying cause of the motor deficits in DS can lead to not 
only a more favorable motor outcome, but also to improved cognitive abilities in 
individuals with DS. In the past, researchers aiming to find and ameliorate motor 
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dysfunction in individuals with DS have focused on the cerebellum, due to the 
substantial changes seen in this region (Aylward et al., 1997; Pinter et al., 2001; 
Guidi et al., 2011) and its roles in both motor and cognitive processes 
(Akshoomoff et al., 1992; Desmond et al., 1997; Fabbro et al., 2004; Tavano et 
al., 2007). For example, Gutierrez-Castellanos et al. (2013) attempted to rescue 
long-term cerebellar-based (motor) learning in a mouse model of DS using a 
Sonic hedgehog (Shh) agonist to promote granule cell precursor generation. 
While their treatment rescued the neuroanatomical changes in the cerebellum, 
motor function was not restored, pointing to the contribution of another motor 
control center to the observed deficits. Thus, in the present study, we look for the 
first time at the potential role of the SC in the motor dysfunction observed in 
people with DS and in mouse models of the syndrome.  
 SC development is well characterized. During neural tube development, 
morphogen gradients, which arise from either the roof plate or the floor plate, 
direct dorso-ventral patterning (Ericson et al., 1995; Roelink et al., 1995). These 
gradients set up 12 distinct progenitor domains along the ventricular zone (VZ) 
surrounding the central canal. Of these 12 domains, 7 are in the dorsal portion of 
the SC and 5 are in the ventral portion of the SC (Tanabe and Jessell, 1996; 
Wine-Lee et al., 2004). As development proceeds, dorsal progenitors give rise to 
sensory afferents and local interneurons within the dorsal horn of the SC 
(Tanabe and Jessell, 1996). Ventral progenitors, however, give rise to motor 
neurons and several classes of local interneurons within the ventral horn. These 
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ventral progenitors are subdivided into distinct subclasses of postmitotic cells 
through various degrees of sensitivity to the Shh gradient that emanates from the 
floorplate of the neural tube. From dorsal to ventral, these domains are identified 
as p0, p1, p2, pMN, and p3 and give rise to V0, V1, V2, MN, and V3 cell types, 
respectively (Tanabe and Jessell, 1996; Briscoe et al., 2000; Jessell, 2000). A 
multitude of studies have identified a strict transcription factor code that 
molecularly specifies each progenitor domain and their progeny (Grillner and 
Jessell, 2009; Alaynick et al., 2011; Francius et al., 2013).  
One critical master switch in the early specification of ventral progenitors 
is Oligodendrocyte transcription factor 2 (Olig2), which is incidentally located on 
Hsa21 and is, therefore, triplicated in people with DS as well as in most mouse 
models of the syndrome, including the B6EiC3Sn.BLiA-Ts(1716)65Dn/DnJ 
(Ts65Dn) model used in the present study (Chakrabarti et al., 2010). In the 
developing SC, Olig2 is essential for proper patterning and development of 
ventral neurons and glia (Novitch et al., 2001). Therefore, this gene’s integral role 
within the SC coupled with its triplication in DS suggest that it may play a leading 
role in the motor dysfunction seen in DS due to altered levels of expression.   
Olig2 is a member of the basic helix-loop-helix (bHLH) transcription factor 
family and is expressed by the progenitor cells within the pMN domain. Lying 
ventrally to this domain is the p3 domain, which is marked by NK2 homeobox 2 
(Nkx2.2) expression (Briscoe et al., 2000). Dorsal to the pMN domain are the p2, 
p1, and p0 domains, which are marked by Iroquois homeobox 3 (Irx3) expression 
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(Briscoe et al., 2000). Strict boundaries maintained through cross-repression 
between Nkx2.2, Olig2, and Irx3 are necessary for the development of distinct 
cell types (Jessell, 2000; Sun et al., 2001; Chen et al., 2011). As such, Olig2 not 
only specifies spinal motor neurons (MNs) (and later in development spinal 
oligodendrocytes (OLs)), but its interaction with Nkx2.2 and Irx3 is integral for 
proper specification of all local ventral interneurons (INs).  
All spinal MNs are generated from Olig2 expressing progenitor cells within 
the pMN between embryonic days (E) 9 and 12, with neurogenesis peaking at 
E9.5 (Li et al., 2011; Meijer et al., 2012). Commitment to a MN fate has been 
shown to be linked to both NK6 homeobox 1 (Nkx6.1) and Neurogenin 2 (Ngn2) 
expression (Sander et al., 2000; Novitch et al., 2001; Takebayashi et al., 2002; 
Ma et al., 2008) in pMN progenitors. Shortly after their generation, MN 
progenitors terminally differentiate into Olig2- postmitotic MNs and migrate away 
from their initial positions in the VZ towards the lateral portions of the ventral horn 
(Thaler et al., 2004). As MN progenitors shift away from the VZ, they stop 
expressing Olig2 and begin to express Homeobox protein HB9 (Hb9) and ISL 
homeodomain 1 (Isl1) (Thaler et al., 2004). Isl1 is also expressed by a subclass 
of dorsally-derived INs, which receive inputs from cutaneous afferents and make 
excitatory glutamatergic synapses on MNs to regulate grip strength and grasping 
(Bui et al., 2013).  
Although MN production ceases by E12.5, Olig2+ pMN progenitors 
continue to be produced. These “late” progenitors undergo a fate-switch and 
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become restricted to the OL lineage (Li et al., 2011). This MN-OL switch is 
thought to be dependent on the phosphorylation state of OLIG2 on Serine 147 
(S147). This is supported by the fact that the S147 site is phosphorylated from 
E9-E12, while MNs are produced, and dephosphorylated at E12, when 
production shifts to oligodendrocyte precursors (OPCs) (Sun et al., 2001; Li et 
al., 2011; Meijer et al., 2012). One hypothesis suggests that the phosphorylation 
of OLIG2 at S147 is Notch-dependent (Li et al., 2011). Notch is of note as it has 
roles in neural proliferation and differentiation, including specific roles in OL 
differentiation, maturation, and myelination (Louvi and Artavanis-Tsakonas, 
2006), and its activity is linked to several genes located on Hsa21 (Fischer et al., 
2005; Fernandez-Martinez et al., 2009).  
Some members of the Nkx homeodomain superfamily are also important 
for early patterning of the SC. One such member is Nkx6.1, whose expression 
spans the p2 and p3 progenitor domains in the developing SC and has a critical 
role in generating V2 INs and MNs and in maintaining proper spatial distribution 
of V1 INs (Sander et al., 2000). The V2 IN population can be further subdivided 
into several subclasses: V2a, V2b, and V2c (Alaynick et al., 2011). Of interest in 
looking at motor function are Visual system homeobox 2 (Chx10) expressing V2a 
excitatory INs that mediate left-right coordination during walking (Alaynick et al., 
2011; Francius et al., 2013). Another member of this transcription factor 
superfamily is Nkx2.2. Nkx2.2 interacts with Olig2 to regulate OPC generation 
and/or differentiation and also specifies the p3 domain, whose cells give rise to 
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V3 glutamatergic INs (Novitch et al., 2001; Sun et al., 2001; Takebayashi et al., 
2002; Li et al., 2011). These INs have been shown to play a role in rhythmicity 
during walking and in maintaining CPG robustness (Francius et al., 2013; Lu et 
al., 2015).  
First described in 1911 (Brown), CPGs are local motor circuits within the 
SC that operate independent of higher cortical structures (Marder and Bucher, 
2001). In the lumbar SC, CPGs regulate the flexion and extension of the limbs 
and rhythmicity during locomotion (walking, running, swimming, etc.) (Marder and 
Bucher, 2001). Ventral spinal INs play a crucial role in CPGs, and, while both 
excitatory and inhibitory INs are important, the inhibitory INs are not necessary 
for rhythmic locomotion (Cowley and Schmidt, 1995; Jessell, 2000). Excitatory 
INs, specifically V2a and V3, however, are crucial for proper CPG regulation. V2a 
and V3 INs make ipsilateral projections that mediate left-right coordination 
(Crone et al., 2008), and contralateral connections to ensure both left-right 
coordination and smooth rhythmicity in locomotion (Zhang et al., 2008; Hayashi 
et al., 2018), respectively. Because of their involvement in the regulation of 
CPGs, the proximity of their progenitor domains to pMN, and their interaction with 
pMN-derived cells, V2a and V3 INs may have a role in the motor dysfunction 
seen in DS.  
To better characterize the roles of all these neural and glial populations in 
DS-related motor dysfunction, we utilized a well characterized mouse model of 
the syndrome known as the Ts65Dn mouse model (Reeves et al., 1995; Rachidi 
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and Lopes, 2008; Rueda et al., 2012). Hsa21 has orthologous genes on mouse 
chromosomes (Mmu) 16, 17, and 10, and many trisomic mouse models have 
been developed based on these syntenic regions in order to study DS (Reeves et 
al., 1995; Rachidi and Lopes, 2008; Haydar and Reeves, 2012; Rueda et al., 
2012). The Ts65Dn model has an extra freely segregating marker chromosome 
containing roughly 100 triplicated Mmu16 genes that are syntenic to Hsa21 
genes (Duchon et al., 2011). Additionally, Ts65Dn mice have been shown to 
display motor changes that are similar to those seen in people with DS (Costa et 
al., 1999; Hampton et al., 2004; Rachidi and Lopes, 2008; Haydar and Reeves, 
2012; Rueda et al., 2012). Specifically, when characterizing locomotive 
dysfunction, Ts65Dn mice were found to display a higher stride frequency, 
shorter stride length, briefer stride duration, higher proportion of stride spent in 
hind limb stance, and decreased ability to brake when compared to the controls 
(Costa et al., 1999; Hampton et al., 2004). These phenotypes were more 
pronounced at faster, rather than slower, walking speeds (Costa et al., 1999; 
Hampton et al., 2004). Ts65Dn mice also have an irregular gait, slower running 
speed, and swimming patterns that parallel these gait deficits (slower speed and 
inconsistent strokes) (Costa et al., 1999). Grip strength and regulation are also 
significantly impaired in Ts65Dn mice compared to their euploid littermates 
(Costa et al., 1999). The parallels in the motor dysfunction seen in individuals 
with DS and the Ts65Dn mouse model make the Ts65Dn mouse an attractive 
model for studying the underlying factors contributing to motor deficits seen in 
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DS.  
 In this study, we looked at the impact of trisomy 21 on SC development as 
a potential player in the motor dysfunction in DS. We used immunohistochemical 
staining to visualize and quantify OLs, INs, MNs and their precursors in the 
developing (E12.5, E14.5) SC of the Ts65Dn mouse. We found that the OL 
population was unchanged at E12.5 and E14.5, although there were some small 
alterations in subsets of this population at E12.5. The MN population was 
increased at E12.5, with significant increases in the migrating (but not terminally 
differentiated) population. However, at E14.5, the MNs were normalized to 
euploid levels. Finally, the PAX6- and NKX2.2-expressing IN populations showed 
significant increases in both overall and abventricular populations, at E12.5. 
NKX2.2 was unchanged at E14.5, and NKX6.1 was not affected at either time-
point. These results suggest that alternations in gene expression caused by the 
extra chromosomal segment lead to delays in MN and perhaps OL maturation, 
and dysregulation of IN inputs to CPGs, which, together, may be a root of the 
motor dysfunctions seen in DS.  
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METHODS 
 
Animals 
All murine experiments were conducted according to international ethical 
standards and approved by the Institutional Animal Care and Use Committees 
(IACUC) of Boston University. Animals were housed in cages with standard 
bedding and a nestlet square. Rodent chow and water were available ad libitum. 
The colony was maintained on a 12:12 light/dark cycle, with lights on at 7:00 AM. 
B6EiC3Sn.BLiA-Ts(1716)65Dn/DnJ (Ts65Dn; stock number 005252) mice 
were purchased from The Jackson Laboratory (Bar Harbor, ME). Ts65Dn female 
mice were bred with B6EiC3Sn.BLiAF1/J (F1 hybrid; stock number 003647) 
males. Studies were performed at embryonic days (E)12.5 and E14.5.  
 
Tissue collection and sectioning 
Embryos resulting from timed-pregnancies were collected, viscera were 
mostly removed, and embryos were fixed for 1-24hr in 4% paraformaldehyde 
(PFA) at 4°C. Embryos were then washed three times in 1x phosphate-buffered 
saline (PBS), placed in 30% sucrose for 16-24h at 4°C. Embryos were then 
decapitated and embedded in Optimal Cutting Temperature compound (OCT; 
Sakura, Torrance, CA), frozen, and kept at -80˚C until use.  
16 µm-thick sections were taken on the Microm H550 cryostat 
(ThermoFisher Scientific, Waltham, MA). Whole-body serial coronal sections 
were taken, from rostral to caudal, and mounted on Superfrost® Plus slides 
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(Fisher Scientific, Waltham, MA). Slides were dried at room temperature and 
then stored at -80˚C.  
 
Genotyping and sex determination 
Embryonic limb buds were extracted from each embryo at the time of 
collection and digested overnight at 55˚C in a solution of digestion buffer and 
200ug/mL Proteinase K (Denville Scientific, Holliston, MA). 
Phenol/chloroform/isoamyl alcohol (Fisher Bioreagents) was then added to the 
digested limb buds, and the tubes were shaken then spun down. Limb bud DNA 
was then extracted and ethanol precipitated. Excess ethanol was removed and 
the purified DNA pellet was reconstituted in standard elution buffer (EB).  
Genotyping and sex determination were performed by polymerase chain 
reaction (PCR) using specific primers for theTs65Dn translocation breakpoints on 
Mmu16 and Mmu17, and the sex determining region of the Y chromosome 
(SRY). Typically, a multiplexed PCR was performed on each sample to include a 
positive control primer set targeting the ROSA26 locus. To confirm the accuracy 
of the translocation-based genotyping, genotyping was also carried out by 
quantitative (q) PCR using specific primers for the amyloid beta precursor protein 
(App) gene, which is triplicated in Ts65Dn mice, and ApoB, which is not 
triplicated in these mice (Table 1) (Liu et al., 2003; Reinholdt et al., 2011).  Their 
relative quantities were compared, and animals that showed a 1.5-fold 
expression in App compared to ApoB were designated as trisomic. 
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Tail snips from the mothers were taken for genotyping in the same manner 
as the limb buds.  
 
Table 1. Primer sequences for genotyping of embryonic and adult mice and 
sex-determination of embryonic mice. 
 
 Target sequence Internal control sequence 
Ts65Dn 
(PCR)  
Chr17fwd: 
GTGGCAAGAGACTCAAATTCAAC 
IMR8545: 
AAAGTCGCTCTGAGTTGTTAT  
Chr16rev: 
TGGCTTATTATTATCAGGGCATTT 
IMR8546: 
GGAGCGGGAGAAATGGATATG 
Ts65Dn  
(qPCR) 
Appfwd: 
TGCTGAAGATGTGGGTTCGA 
Apobfwd: 
CACGTGGGCTCCAGCATT 
Apprev: 
GACAATCACGGTTGCTATGACAA 
Apobrev: 
TCACCAGTCATTTCTGCCTTTG 
AppProbe: 
FAM-
CAAAGGCGCCATCATCGGACTCA-
TAMRA 
ApobProbe: 
VIC-
CCAATGGTCGGGCACTGCTCAA-
TAMRA 
Sex 
determi-
nation 
SRY-fwd: 
GCTGGGATGCAGGTGGAAAA 
IMR8545: 
AAAGTCGCTCTGAGTTGTTAT  
SRY-rev: 
TGATGGCATGTGGGTTCCTG 
IMR8546: 
GGAGCGGGAGAAATGGATATG 
   
Immunohistochemistry 
Different immunohistochemistry (IHC) protocols were used to optimize 
detection of target proteins. Each protocol is listed separately below. See Table 2 
for specific antibody information.  
Set 1: E12.5; Olig2, Isl1, Pax6 
 Slides were washed in 1x PBS for 20 minutes, then incubated in a 70˚C 
water-bath for 35 minutes in a 1:10 solution of HistoVT One® (Nacalai Tesque, 
Kyoto, Japan) in Milli-Q® water (Millipore, Billerica, MA) in a Coplin jar for antigen 
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retrieval. After washing the slides in 3 changes of 1x PBS for 5 minutes, they 
were incubated with a blocking solution of 10% normal goat serum (NGS; Sigma-
Aldrich, St. Louis, MO) in 0.3% Triton X-100 (T8532, Sigma) and 1x PBS (PBS-
T), for 1 hour at room temperature (RT). Next, slides were incubated at 4˚C 
overnight with mouse anti-Olig2 (1:500; Millipore), rabbit anti-Isl1 (1:100; 
Proteintech, Rosemont, IL), and mouse anti-Pax6 (1:50; DSHB, Iowa City, IA) in 
a solution of 10% NGS in 0.3% PBS-T. Slides were washed in 3 changes of 
0.01% PBS-T for 5 minutes, then incubated at RT for 1 hour with Alexa Fluor 546 
goat anti-mouse IgG2a, Alexa Fluor 633 goat anti-rabbit IgG, and Alexa Fluor 
488 goat anti-mouse IgG1 (1:250; Invitrogen, Carlsbad, CA) in a solution of 10% 
NGS in 0.3% PBS-T. Slides were washed in 3 changes of 0.01% PBS-T for 5 
minutes, then for 5 minutes in 1x PBS. Slides were then immersed in 70% 
ethanol for 5 minutes, then incubated with the Autofluorescence Eliminator 
Reagent (Millipore) for 5 minutes at RT to reduce autofluorescence. This was 
followed by immersion in 3 changes of 70% ethanol for 1 minute each time. The 
slides had one final wash in 1x PBS for 5 minutes and were mounted with a 
Vectashield mounting solution containing DAPI (Vector Laboratories, Burlingame, 
CA).        
Set 2: E12.5; Nkx2.2, Nkx6.1 
 Slides were washed in 1x PBS for 30 minutes, then incubated in a 70˚C 
water-bath for 35 minutes in a 1:10 solution of HistoVT One® in Milli-Q® water in 
a Coplin jar for antigen retrieval. After washing the slides in 3 changes of 1x PBS 
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for 5 minutes, they were incubated with a blocking solution of 10% NGS in 0.3% 
PBS-T, for 1 hour at RT. Next, slides were incubated at 4˚C overnight with 
mouse anti-Nkx2.2 (1:50; DSHB) and mouse anti-Nkx6.1 (1:50; DSHB) in a 
solution of 10% NGS in 0.3% PBS-T. Slides were washed in 3 changes of PBS 
for 5 minutes, then incubated at RT for 1 hour with Alexa Fluor 546 goat anti-
mouse IgG2b and Alexa Fluor 633 goat anti-mouse IgG1 (1:250; Invitrogen) in a 
solution of 10% NGS in 0.3% PBS-T. Slides were washed in 2 changes of 0.01% 
PBS-T for five minutes and then in one change of 1x PBS for 5 minutes, and 
were mounted with a Vectashield mounting solution containing DAPI.        
Set 3: E14.5; Nkx2.2, Nkx6.1, Olig2 
Slides were washed in 1x PBS for 20 minutes, then incubated with a 
blocking solution of 10% NGS in 0.1% PBS-T, for 10 minutes at RT. Following a 
5-minute wash in 1x PBS, slides were incubated overnight at 4˚C with mouse 
anti-Olig2 (1:500), rabbit anti-Nkx2.2 (1:100; Proteintech), and mouse anti-
Nkx6.1 (1:25) in a solution of 2% NGS in 1x PBS. Slides were washed in 3 
changes of 1x PBS for 5 minutes, then incubated at RT for 2 hours with Alexa 
Fluor 546 goat anti-mouse IgG2a, Alexa Fluor 633 goat anti-rabbit IgG, and 
Alexa Fluor 488 goat anti-mouse IgG1 (1:250) in a solution of 2% NGS in 0.1% 
PBS-T. Slides were washed in 3 changes of PBS for 5 minutes and mounted with 
a Vectashield mounting solution containing DAPI.  
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Set 4: E14.5; Olig2, Isl1 
Slides were washed in 1x PBS for 20 minutes, then incubated with a 
blocking solution of 20% NGS in 0.1% PBS-T, for 30 minutes at RT. Following a 
5-minute wash in 1x PBS, slides were incubated overnight at 4˚C with mouse 
anti-Olig2 (1:500) and rabbit anti-Isl1 (1:100) in a solution of 2% NGS in 1x PBS. 
Slides were washed in 3 changes of 1x PBS for 5 minutes, then incubated at RT 
for 1 hour with Alexa Fluor 546 goat anti-mouse IgG2a and Alexa Fluor 633 goat 
anti-rabbit IgG (1:250) in a solution of 2% NGS in 0.1% PBS-T. Slides were 
washed in 3 changes of 0.01% PBS-T for 5 minutes and mounted with a 
Vectashield mounting solution containing DAPI.  
 
Table 2. Antibody information for immunohistochemistry. 
1° 
Antibody 
Company Catalog # 1° Antibody 
Dilution 
2° Antibody 2° Antibody 
Dilution 
Mouse 
anti-Olig2 
Millipore MABN50 1:500 Alexa Fluor 546 
goat anti-mouse 
IgG2a 
1:250 
Rabbit anti- 
Nkx2.2 
Proteintech 13013-1-
AP 
 
1:100 Alexa Fluor 633 
goat anti-Rabbit 
IgG 
1:250 
Mouse 
anti- 
Nkx6.1 
DSHB F55A10 
 
1:25-1:50 Alexa Fluor 488 
or 633 goat anti-
mouse IgG1 
1:250 
Rabbit anti-
Isl1 
Proteintech 15661-1-
AP 
 
1:100 Alexa Fluor 633 
goat anti-Rabbit 
IgG 
1:250 
Mouse 
anti-Pax6 
DSHB Pax6-s 
 
1:50 Alexa Fluor 488 
goat anti-mouse 
IgG1 
1:250 
 
Mouse 
anti-Nkx2.2 
DSHB 74.5A5-s 1:50 Alexa Fluor 546 
goat anti-mouse 
IgG2b 
1:250 
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Imaging and cell counting 
Images were taken using Carl Zeiss LSM 710 NLO confocal microscope. 
Tiled images were necessary in order to capture the entire bilateral ventral horn 
region of interest in each SC section. Either 4 or 9 tiles, each with a depth of 16 
µm, were taken of two serial caudal slices per animal. Antibody-labelled cells 
within the ventral horn of the SC were counted bilaterally using Zeiss LSM Image 
Browser (Zeiss) and FIJI (ImageJ).  
Subgroups were made for each cell type to more accurately characterize 
population changes in the SC. These subdivisions are described below: 
1) At E12.5, there was a large OLIG2+ population in the ventricular pMN 
domain, as well as a population that was migrating away from the 
ventricular zone (VZ). These were distinguished as “ventricular” and 
“abventricular” populations, respectively (Fig. 3B).   
2) At both E12.5 and E14.5, there were three distinct groups of ISL1+ cells. 
One group consisted of dI3 dorsally-derived INs and was not counted, 
since we were only counting Isl1+ MNs derived from the pMN domain. The 
other two groups of ISL1+ cells were MN clusters, and counted as such. 
Specifically, at E12.5, some MN-fated ISL1+ cells were dispersed between 
their starting positions at the ventricle and their terminal location within MN 
columns. As such, they were denoted as “migrating.” Lastly, all cells at 
E12.5 and E14.5 that were ISL+ and organized within MN columns were 
simply referred to as “MNs” (Fig. 9B).  
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3) At E12.5, PAX6+, NKX2.2+, NKX6.1+ cells were also denoted as 
“ventricular” and “abventricular,” since similar to OLIG2+ cells, there were 
2 distinct populations, one in the VZ and the other abventricular in the 
ventral horn (Figs. 11B, 14B, and 17B, respectively).  
 
Data analysis  
Data analysis was completed in Microsoft Excel (Microsoft Office 365) and 
SigmaPlot (SigmaPlot). Cell counts from the spinal cord (SC) ventral horn were 
processed first by image, then by animal (two images were taken from each 
animal), and finally by genotype.  
All cell density counts were normalized to a (100µm)3 region of interest 
(ROI) unless otherwise noted, and outliers were accounted for statistically within 
each genotype by image and then by animal. All variables were assessed with a 
two-tailed, Independent Samples Student’s t-test, and passed both the Shapiro-
Wilks Normality test and an Equal Variance test, unless otherwise noted. 
Additional statistical tests are noted where applicable.  
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RESULTS 
Immunohistochemical analysis of spinal neural and glial populations at 
E12.5 
In order to view the distribution of OLs, MNs, and INs in the SC at E12.5, 
we first stained for OLIG2, ISL1, and Paired box 6 (PAX6) in Ts65Dn mice (n=5) 
and their euploid littermates (n=4) (Fig. 1). Cells that are OLIG2+/ISL1- are OL-
fated, and all OLIG2+ cells at E12.5 were ISL1- since MN production by this time 
has ceased. To determine if triplication of Olig2 had an effect on V3 INs and INs 
marked by NKX6.1 in the SC at E12.5, we also stained for NKX2.2 and NKX6.1 
in Ts65Dn mice (n=5) and their euploid littermates (n=3) (Fig. 12). Importantly, 
NKX6.1 can also be co-expressed within a group of ISL1+ MNs (Fig. 17B), these 
were excluded from counting in order to restrict the NKX6.1 counts to IN 
populations only. 
Oligodendrocytes at E12.5 
There were no changes in overall OLIG2+ cell density in Ts65Dn mice 
compared to their euploid littermates (Fig. 2). We then further analyzed the 
OLIG2+ population by cells in the pMN domain and those migrating and found no 
change in either group (Fig. 3A). We also assessed differences in the dispersion 
of OLIG2+ cells away from the ventricle to analyze their migration pattern and 
found no change (Figs. 4 and 5; failed equal variance). The length of the OLIG2+ 
pMN domain was also measured relative to the total rostrocaudal expansion of 
the SC and was also unchanged (Figs. 6 and 7).  
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While statistically non-significant, a few genotype-phenotype relationships 
at E12.5 may be of note: 1) a 31% increase in the Ts65Dn ventricular population 
of OLIG2+ cells, 2) a 26% decrease in OLIG2+ cell dispersion distance from the 
midline in Ts65Dn mice, and 3) a 21% increase in the Ts65Dn pMN domain 
length. These changes may indicate some dysregulation of gliogenesis and glial 
cell commitment and maturation, since the pMN domain itself is increased in 
size, containing a greater number of cells which seem to linger around the VZ for 
longer in the Ts65Dn SCs.  
Motor neurons at E12.5 
The total ISL1+ cell population (combined migrating and MN cohorts) 
trended toward an increase in Ts65Dn mice compared to their euploid littermates 
(Fig. 8; 127.8% ± 4.66% vs. 100% ± 12.2%; p=.077). When further broken into 
two cohorts – migrating ISL1+ cells and terminally differentiated MNs – the size of 
the MN population was not changed (Fig. 9A), but the migrating ISL1+ cells were 
significantly increased in trisomic animals (Fig. 9A; 212.7% ± 12.9% vs. 100% ± 
2%; p<.001; failed equal variance test).  
Interneurons at E12.5 
The total PAX6+ IN population (combined ventricular and abventricular) 
was significantly increased in Ts65Dn mice compared to euploid animals (Fig. 
10; 146.9% ± 11.48% vs. 100% ± 8.2%; p=.016). Upon further inspection by 
location within the ventral horn, ventricular PAX6+ cells (normalized to a (10µm)3 
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ROI) showed no difference in density (Fig. 11A). However, the abventricular 
PAX6+ group was significantly increased in trisomic vs. euploid mice (Fig. 11A; 
163.5% ± 10.3% vs. 100% ± 8.1%; p=0.012).  
 Total NKX2.2+ cell population showed no change in the Ts65Dn vs. 
euploid mice (Fig. 13). When this population was further broken down into 
ventricular and abventricular groups, there was no change in the ventricular 
population (Fig. 14A) but a significant increase in the abventricular population 
was found in the trisomic mice (Fig. 14A; 118% ± 3.5% vs. 100% ± 0.9%; 
p=.0069). The length of the NKX2.2+ p3 domain relative to the total rostrocaudal 
expansion of the SC was not changed (Fig. 15).  
Although non-significant, there was a 25% increase in the Ts65Dn 
ventricular NKX2.2 population and a 15% increase in the relative length of the p3 
domain. This may be of note, as a decreased NKX2.2 population and p3 domain 
was expected due to the cross-repressive relationship between OLIG2 and 
NKX2.2. This increase, however, may be linked to the increase of OLIG2-
expressing cells, since at E14.5 NKX2.2 binds with OLIG2 (and is therefore co-
expressed) during OPC differentiation (Li et al., 2011).  
 The total NKX6.1 cell population remained unchanged in the Ts65Dn mice 
(Fig. 16). This population was categorized into ventricular and abventricular 
populations, and no change was found in either group (Fig. 17A). We then 
measured the length of the NKX6.1+ ventricular domain relative to the total 
rostrocaudal expansion of the SC and, again, there was no change in the relative 
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length of the Ts65Dn NKX6.1+ domain (Fig. 18). 
 
Immunohistochemical analysis of spinal neural and glial populations at 
E14.5 
 In order to quantify the amount and distribution of OLs, MNs, and INs in 
the SC at E14.5, we stained for OLIG2, NKX2.2, NKX6.1, and ISL1 in Ts65Dn 
mice (n=6) and their euploid littermates (n=7) (Figs. 19 and 23). At this age, all 
OLIG2+ cells are ISL1-, indicating an OL fate restriction, while NKX2.2+ cells are 
within the V3 IN lineage, and NKX6.1+ cells are within the V1, V2, and V3 IN 
lineages. Again, NKX6.1 can be co-expressed within a group of ISL1+ MNs (Fig. 
17B) and these were excluded from counting in order to restrict the NKX6.1 
counts to IN populations only. ISL1+ cells again marked MNs that are by this 
developmental time point fully clustered into MN columns. 
Oligodendrocytes at E14.5 
No significant differences were found in the OLIG2+ cell population, i.e. 
OL-fated cells, in Ts65Dn mice compare to euploid animals (Figs. 20, 24).  
Interneurons at E14.5 
 There were no changes in either the NKX2.2 or NKX6.1 cell populations in 
Ts65Dn SCs compared to euploid littermates (Figs. 21 and 22, respectively). 
Motor neurons at E14.5 
ISL1+ cell population was unchanged at E14.5 (Fig. 25). 
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Cross-sectional comparisons of spinal neural and glial populations 
Oligodendrocytes 
 A two-way ANOVA was used to analyze the overall OLIG2+ cell population 
by two independent factors—age and genotype—using the total OLIG2+ cell 
density at E12.5 and average OLIG2+ cell density at E14.5. No significant 
differences were found (Fig. 26).  
Motor neurons 
When assessing total ISL1+ population, we found a trend towards an 
increase at E12.5 and a significant decrease to euploid levels at E14.5. To 
further examine the effect of trisomy on the ISL1+ cell population across the 
E12.5 and E14.5 time-points, we ran a two-way ANOVA. Since MN proliferation 
is ceased by E12.5 and the SC is larger at E14.5 than at E12.5, cell density was 
normalized by ventral horn volume across the time-points for this comparison. 
The ANOVA revealed that when sampled at two independent time points, 
changes in ISL1+ cells were significant by genotype and by age. Specifically, an 
overall increase in ISL1+ cells was observed in trisomic mice compared to 
euploid (Fig. 27; 71.117 ± 3.473 vs. 61.133 ± 3.473; p=.059); and a significant 
decrease in the ISL1+ cell population from E12.5 to E14.5 was observed in both 
trisomic and euploid animals (Fig. 27; 89.138 ± 3.804 vs. 43.091 ± 3.106; 
p<.001); thus there was a significant interaction between age and genotype in the 
ISL1+ population (Fig. 27; p=.028). A Holm-Sidak post hoc test was used to 
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further statistically interrogate these results. This post hoc analysis confirmed 
that there was a significant increase in Ts65Dn ISL1+ population at E12.5 (Fig. 
27; p<.004), and significant decreases within both the euploid (Fig. 27; p<.001) 
and Ts65Dn (Fig. 27; p<.001) populations from E12.5 to E14.5. Like the two-way 
ANOVA and the Independent Samples t-test, the Holm-Sidak post hoc test 
revealed no significant difference between the euploid and Ts65Dn ISL1+ 
population at E14.5 (Fig. 27).   
Interneurons 
 As was done with ISL+ cells, the NKX2.2+ and NKX6.1+ cell density was 
normalized by ventral horn volume across E12.5 and E14.5 for cross sectional IN 
comparisons. 
A two-way ANOVA was used to compare the E12.5 and E14.5 NKX2.2+ 
cell populations, and there were no significant changes (Fig. 28).  
Another two-way ANOVA was used to compare the NKX6.1+ cell 
populations at E12.5 and E14.5, and a significant decrease in cell density 
between E12.5 and E14.5 was revealed in both genotypes (Fig. 29; 100.9 ± 6.25 
vs. 57.3 ± 5.01; p<.001). There were no other significant relationships. Thus, a 
population change based only on age and not genotype was identified.  
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Figures 
 
Figure 1: E12.5 spinal cord; OLIG2, ISL1, PAX6.  OLIG2+ cells denote OL-
fated cells, ISL1+ cells denote MNs, and PAX6+ cells denote IN progenitors. Cells 
in the VH were counted. Cell density was normalized to a (100µm)3 ROI, PAX6+ 
ventricular cells were normalized to a (10µm)3 ROI.   
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Figure 2: Total OLIG2+ cell population at E12.5. Ts65Dn total OLIG2+ 
population density at E12.5, displayed as a percent of euploid. Ts65Dn mice 
showed a non-significant increase in total OLIG2+ cell population (n=5; 
122.81%±15.94%), compared to euploid (dashed line; n=4; 100%±6.01%); 
p=.265.  
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Figure 3: OLIG2+ ventricular and abventricular populations at E12.5. (A) 
Ts65Dn mice (n=5) show a non-significant increase in OLIG2+ ventricular 
population (131.19%±18.41%) compared to euploid littermates (n=4; 
100%±6.49); p=.193. No change in OLIG2+ abventricular population between 
Ts65Dn (n=4; 101.9%±9.19%) and euploid mice (n=3; 100%±3.36%); p=.87. 
Ts65Dn displayed as a percent of euploid (dashed line). (B) Illustration showing 
OLIG2+ ventricular (yellow rectangle) and abventricular (white rectangle) 
populations.  
 
 
 
 
A B 
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Figure 4: OLIG2+ cell dispersion at E12.5; images. Images displaying 
difference in OLIG2+ cell dispersion from the ventricle in the euploid (left) and 
Ts65Dn (right) SC at E12.5.  
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Figure 5: OLIG2+ cell dispersion at E12.5. Ts65Dn total OLIG2+ cell dispersion 
from the midline, at E12.5, displayed as a percent of euploid (dashed line; n=4). 
Euploid OLIG2+ cells dispersed farther from the midline (non-significant), relative 
to total ventral horn width (100%±25.1%), compared to Ts65Dn littermates (n=4; 
74.52%±10.11%); p=.383. 
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Figure 6: OLIG2+ pMN domain length at E12.5, images. Images displaying 
difference in OLIG2+ pMN domain length, relative to total rostrocaudal length of 
ventricular zone in the euploid (left) and Ts65Dn (right) SC at E12.5.  
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Figure 7: OLIG2+ pMN domain length, relative to total rostrocaudal length of 
ventricular zone. pMN domain length shows a non-significant increase in 
Ts65Dn SCs (n=5; 120.97%±11.44%), displayed as a percent of euploid (dashed 
line; n=4; 100%±0.007%); p=.135.  
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Figure 8: Total ISL1+ cell population at E12.5. Ts65Dn total ISL1+ population 
at E12.5, displayed as a percent of euploid. Ts65Dn (n=4) trending toward an 
increase (127.81%±4.66%), compared to euploid (dashed line; n=4; 
100%±12.22%); p=.077. 
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Figure 9: ISL1+ MN and migrating populations at E12.5. (A) Ts65Dn mice 
(n=4) show a non-significant increase in ISL1+ MN population (122.74%±5.78%) 
compared to euploid littermates (n=4; 100%±11.69%); p=.132. ISL1+ migrating 
population is significantly increased in Ts65Dn mice (n=4; 212.7%±12.92%) 
compared to euploid littermates (n=3; 100%±1.99%); p<.001. Ts65Dn displayed 
as a percent of euploid (dashed line). ***p<.001. (B) Illustration showing ISL1+ 
MN (green ovals), migrating (white rectangle), and dorsally-derived dI3 (yellow 
rectangle) populations.  
A B 
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Figure 10: Total PAX6+ cell population at E12.5. Ts65Dn total PAX6+ 
population at E12.5, displayed as a percent of euploid. Ts65Dn (n=5) significantly 
increased (146.92%±11.48%), compared to euploid (dashed line; n=4; 
100%±8.23%); p=.016. *p<.05. 
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Figure 11: PAX6+ ventricular and abventricular populations at E12.5. (A) 
Ts65Dn mice (n=5) show a non-significant increase in PAX6+ ventricular 
population (114.84%±12.05%) compared to euploid littermates (n=4; 
100%±6.44%); p=.349. PAX6+ abventricular population is significantly increased 
in Ts65Dn mice (n=5; 163.53%±10.26%) compared to euploid littermates (n=4; 
100%±8.11%); p<.012. Ts65Dn displayed as a percent of euploid (dashed line). 
*p<.05. (B) Illustration showing PAX6+ ventricular (yellow triangle) and 
abventricular (white oval) populations.  
 
A B 
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Figure 12: E12.5 spinal cord; NKX2.2 and NKX6.1. NKX2.2+ cells denote V3 
INs and NKX6.1+ cells denote INs marked by NKX6.1. Cells in the VH were 
counted. Cell density was normalized to a (100µm)3 ROI. 
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Figure 13: Total NKX2.2+ cell population at E12.5. Ts65Dn total NKX2.2+ 
population at E12.5, displayed as a percent of euploid. Ts65Dn (n=5) showed a 
non-significant increase in total NKX2.2+ cells (124.23%±10.3%), compared to 
euploid (dashed line; n=3; 100%±3.94%); p=.135. 
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Figure 14: NKX2.2+ ventricular and abventricular populations at E12.5. (A) 
Ts65Dn mice (n=5) show a non-significant increase in NKX2.2+ ventricular 
population (125.16%±12.09%) compared to euploid littermates (n=3; 
100%±11.26%); p=.214. NKX2.2+ abventricular population is significantly 
increased in Ts65Dn mice (n=3; 118.68%±3.54%) compared to euploid 
littermates (n=3; 100%±0.89%); p=.007. Ts65Dn displayed as a percent of 
euploid (dashed line). **p<.01. (B) Illustration showing NKX2.2+ ventricular 
(yellow rectangle) and abventricular (white rectangle) populations.  
A B 
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Figure 15: NKX2.2+ p3 domain length relative to total rostrocaudal length of 
ventricular zone. p3 domain length non-significantly increased in Ts65Dn SCs 
(n=5; 115.51%±5.96%), displayed as a percent of euploid (dashed line; n=3; 
100%±13.85%); p=.273. 
	40 
 
Figure 16: Total NKX6.1+ cell population at E12.5. Ts65Dn total NKX6.1+ 
population at E12.5, displayed as a percent of euploid (dashed line). Ts65Dn 
(n=5) showing no change in NKX6.1+ cells (99.37%±12.29%), compared to 
euploid (n=3; 100%±8.56%); p=.972. 
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Figure 17: NKX6.1+ ventricular and abventricular populations at E12.5. (A) 
Ts65Dn mice (n=5) shows a non-significant change in NKX6.1+ ventricular 
population (95.7%±10.29%) compared to euploid littermates (n=3; 100%±9.18%); 
p=.787. NKX6.1+ abventricular population also shows a non-significant change in 
Ts65Dn mice (n=5; 109.51%±18.99%) compared to euploid littermates (n=3; 
100%±8.07%); p=.727. Ts65Dn displayed as a percent of euploid (dashed line). 
(B) Illustration showing NKX6.1+ ventricular (yellow rectangle), abventricular 
(white rectangle), and MN cluster (not counted in NKX6.1 counts) (green oval) 
populations.  
 
A B 
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Figure 18: NKX6.1+ ventricular domain length relative to total rostrocaudal 
length of ventricular zone. NKX6.1+ domain length non-significantly decreased 
in Ts65Dn SCs (n=5; 94.37%±4.54%), displayed as a percent of euploid (dashed 
line; n=3; 100%±5.163%); p=.46. 
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Figure 19: E14.5 spinal cord; OLIG2, NKX2.2, and NKX6.1. OLIG2+ cells 
denote OL-fated cells, NKX2.2+ cells denote V3 INs and NKX6.1+ cells denote 
INs marked by NKX6.1. Cells in the VH were counted. Cell density normalized to 
a (100µm)3 ROI. 
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Figure 20: OLIG2+ cell population at E14.5 (NKX2.2, NKX6.1 set). Ts65Dn 
total OLIG2+ population at E14.5, displayed as a percent of euploid (dashed line). 
Ts65Dn mice (n=6) show no change in OLIG2+ cells (95.38%±8.15%), compared 
to euploid (n=7; 100%±5.31%); p=.635. 
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Figure 21: NKX2.2+ cell population at E14.5. Ts65Dn total NKX2.2+ population 
at E14.5, displayed as a percent of euploid (dashed line). Ts65Dn mice (n=5) 
show no change in NKX2.2+ cells (94.11%±3.31%), compared to euploid (n=7; 
100%±8.15%); p=.575. 
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Figure 22: NKX6.1+ cell population at E14.5. Ts65Dn total NKX6.1+ population 
at E14.5, displayed as a percent of euploid (dashed line). Ts65Dn mice (n=5) 
show a non-significant decrease in NKX6.1+ cells (87.2%±8.13%), compared to 
euploid (n=7; 100%±5.25%); p=.195. 
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Figure 23: E14.5 spinal cord; OLIG2, ISL1. OLIG2+ cells denote OL-fated cells 
and ISL1+ cells denote MNs. Cells in the VH were counted. Cell density was 
normalized to a (100µm)3 ROI. 
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Figure 24: OLIG2+ cell population at E14.5 (ISL1 set). Ts65Dn total OLIG2+ 
population at E14.5, displayed as a percent of euploid. Ts65Dn mice (n=6) show 
no change in OLIG2+ cells (99.55%±6.74%), (dashed line) compared to euploid 
(n=6; 100%±2.2%); p=.951. 
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Figure 25: ISL1+ cell population at E14.5. Ts65Dn total ISL1+ population at 
E14.5, displayed as a percent of euploid (dashed line). Ts65Dn mice (n=6) show 
no change in ISL1+ cells (95.812%±10.24%), compared to euploid (n=6; 
100%±3.61%); p=.688. 
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Figure 26: Change in total OLIG2+ population between E12.5 and E14.5. 
Two-way ANOVA comparing OLIG2+ population by age and genotype. No overall 
effect of genotype was found: euploid (33.57±2.211), Ts65Dn (38.858±2.136); 
p=.299. No overall effect of age was found: E12.5 (37.856±2.366), E14.5 
(36.572±1.963); p=.681. No interaction between genotype and age was found: 
euploid at E12.5 (33.981±3.527), euploid at E14.5 (37.159±2.667), Ts65Dn at 
E12.5 (41.731±3.155), and Ts65Dn at E14.5 (35.985±2.88); p=.164. 
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Figure 27: Change in total ISL1+ population between E12.5 and E14.5. Two-
way ANOVA comparing ISL1+ population by age and genotype. Overall effect of 
genotype revealed a trend toward increased density in the Ts65Dn ISL1+ 
population: euploid (61.133±3.473), Ts65Dn (71.117±3.473); p=.059. An overall 
effect of age was found, with a significant increase in ISL1+ cells at E12.5: E12.5 
(89.138±3.804), E14.5 (43.091±3.106); p<.001. An interaction between genotype 
and age was found: euploid at E12.5 (78.214±5.38), euploid at E14.5 
(44.011±4.393), Ts65Dn at E12.5 (100.063±5.38), and Ts65Dn at E14.5 
(42.17±4.393); p=.028. A Holm-Sidak post-hoc further exposed the age x 
genotype interaction: there were significant effects of age within both the euploid 
population (p<.001) and the Ts65Dn population (p<.001), a significant effect of 
genotype within the E12.5 population (p=.011), and no effect of genotype within 
the E14.5 population (p=.771). SC volume was normalized between these 
populations, as MN production has ceased by E12.5. *p<.05, ***p<.001. 
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Figure 28: Change in total NKX2.2+ population between E12.5 and E14.5. 
Two-way ANOVA comparing NKX2.2+ population by age and genotype. There 
was no overall effect of genotype: euploid (42.545±2.611), Ts65Dn 
(46.967±2.393); p=.23. No overall effect of age was found: E12.5 
(47.965±2.763), E14.5 (41.547±2.215); p<.089. No interaction between genotype 
and age was found: euploid at E12.5 (42.782±4.368), euploid at E14.5 
(42.309±2.86), Ts65Dn at E12.5 (53.147±3.384), and Ts65Dn at E14.5 
(40.786±3.384); p=.113. SC volume was normalized between these populations, 
as IN production has ceased by E12.5. 
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Figure 29: Change in total NKX6.1+ population between E12.5 and E14.5. 
Two-way ANOVA comparing NKX6.1+ population by age and genotype. There 
was no overall effect of genotype: euploid (82.749±5.907), Ts65Dn (78.5±5.414); 
p=.603. An overall effect of age was found, with a significant increase in NKX6.1+ 
cell density at E12.5: E12.5 (100.927±6.251), E14.5 (61.24±6.47); p<.001. No 
interaction between genotype and age was found: euploid at E12.5 
(104.257±9.884), euploid at E14.5 (61.24±6.47), Ts65Dn at E12.5 
(103.598±7.656), and Ts65Dn at E14.5 (53.402±7.656); p=.66. SC volume was 
normalized between these populations, as IN production has ceased by E12.5.  
***p<.001. 
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DISCUSSION 
 
 In this study, we examined the effect of trisomy on OLs, MNs, and INs in 
the developing SC of the Ts65Dn mouse model of DS. Overall, all of these cell 
populations were affected in the trisomic SC, although to different extents. These 
findings demonstrate novel alterations in a heretofore unstudied area of the 
central nervous system and may be related to some of the debilitating motor 
effects in DS. MNs were the most affected cell type, with significant changes in 
number and migration. Additionally, we found an altered distribution of OL and IN 
cells within the ventral horn, indicating effects on genesis, differentiation, and/or 
maturation of the neural and glial progenitors in the Ts65Dn SC, and 
dysregulations in the local CPGs that direct locomotion. The MN and V3 IN 
populations that were increased at E12.5 had normalized to euploid levels by 
E14.5, showing that this is a plastic period of SC development, during which 
processes critical for normal cell development and survival are affected by 
trisomy.  
Since Olig2 is triplicated in both humans with DS and in mouse models of 
the syndrome, we expected to find increased (up to 1.5x) expression of OLIG2, a 
marker of MN and OL precursors, in the developing SC. This expectation was 
supported by preliminary gene expression data which showed that at E12.5, 
Olig2 expression was increased 1.5-fold and Hb9 expression (marking MNs) was 
also increased in Ts65Dn animals compared to euploids. Interestingly, these 
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data also showed that these gene expression levels were normalized by E14.5, 
indicating rapid plasticity in SC development during this developmental time 
window. We also expected to find that, because of cross-repression between cell 
groups from adjacent domains, increases in OLIG2-expressing cells would 
correlate with decreases in NKX2.2- and PAX6-expressing cells. The preliminary 
gene expression data somewhat supported this expectation, as Nkx2.2 
expression was found to be reduced in Ts65Dn mice at E14.5, while Ts65Dn Irx3 
expression (whose expression is closely related to that of Pax6) remained 
unchanged (preliminary data from Dr. Nadine Aziz).  
 In the current study, we used IHC to stain E12.5 and E14.5 Ts65Dn SCs 
to define ventricular progenitor domains and postmitotic cell types. We used 
antibodies against OLIG2, ISL1, PAX6, NKX2.2, and NKX6.1 to mark OL, MN, 
and IN progenitors, respectively (Jessell, 2000; Lu et al., 2015).  
Although there were slight increases in the pMN length and ventricular 
OLIG2+ population and slight decreases in the proportion and distance of 
migrating OLIG2+ cells at E12.5, there were no significant changes found in this 
population at either E12.5 or E14.5.  
The total ISL1 expression, representing MNs, trended towards an increase 
at E12.5 in Ts65Dn mice but was decreased to euploid levels at E14.5. Since we 
saw this trend at E12.5, we subdivided the ISL1+ cell population into a migrating 
group and a terminally differentiated group that clustered within motor columns 
and found that there was an over 2-fold increase in the migrating ISL1+ cell 
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population in Ts65Dn SCs. Coupled with the changes in the OLIG2+ population, 
these results suggest there is delay in cell differentiation and migration in cells 
derived from the pMN domain in Ts65Dn mice.  
Cell proliferation and cell cycle exit in the pMN are regulated by Olig2 
activity in conjunction with expression of other genes. Olig2 promotes 
neurogenesis, and in the absence of expression of transcription factors, such as 
Nkx6.1 or Ngn2, will maintain cells in a proliferative state (Sander et al., 2000; 
Novitch et al., 2001). In this case of increased Olig2 expression and increased 
number of ventricular OLIG2+ cells in Ts65Dn mice, we don’t see any significant 
change in NKX6.1 expression. Therefore, the differentiation of pMN progenitors 
may be delayed (or slowed) because of insufficient Olig2 downregulation. To 
better pinpoint whether these changes in the pMN population are due to 
neurogenesis, cell cycle exit, migration, or differentiation defects, in vivo 
neurogenesis assays (using EdU as a marker of cycling cells) coupled with live-
tissue time lapse imaging are needed.  
 In addition, NOTCH signaling may be implicated in the observed pMN 
changes, as well. Since at E12.5 all ISL1+ cells are OLIG2- and all OLIG2+ cells 
are ISL1-, it does not appear that the MN-OL fate switch, which is thought to be 
mediated by NOTCH signaling around E10.5, is delayed (Li et al., 2011). 
However, NOTCH is also known to contribute to MN differentiation, as was 
shown pharmacologically in humans by Tan et al. (2016) and to the 
differentiation and regulation of OPCs (Louvi and Artavanis-Tsakonas, 2006). 
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Since these intracellular signaling cascades are intricately regulated, the 
disproportionality of NOTCH pathway components in pMN cells with increased 
Olig2 gene expression may underlie the dysregulations we characterized in these 
cell populations.  
Interestingly, in both the euploid and Ts65Dn mice, there was a huge 
decrease in the density of ISL1+ cells between E12.5 and E14.5. Previous 
studies have shown that, from E11.5 to E15.5, programmed cell death (PCD) in 
the mouse SC claims about half of the total MN population, acting in the lumbar 
region largely between E12.5 and E14.5 (Lance-Jone, 1982; Yamamoto and 
Henderson, 1999). This was observed in both the euploid and trisomic 
populations in this study. However, our data suggest that PCD (or other types of 
cell death) are more abundant in Ts65Dn SCs, as we saw a larger reduction (by 
about 70%) in ISL1+ cell density between E12.5 and E14.5 in the trisomic mice 
compared to euploid controls. Spinal MN PCD is thought to be regulated by 
many factors, including but not limited to morphogens, trophic factors, 
competitive innervation of muscle targets, and synapse formation (Oppenheim, 
1991; Banks and Chamberlain, 2005), so this observation may be linked to the 
muscular hypotrophy, desensitization to Shh signaling, or impaired synapse 
formation seen in DS (Oppenheim et al., 1999). In addition, MNs begin to 
innervate target muscles around E12.5 (Taher et al., 2011), so the hypotonia 
observed at birth and throughout life (Henderson et al., 1981; Hampton et al., 
2004) in individuals with DS and in Ts65Dn mice may play a part in reducing the 
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requirement for spinal MNs during development, therefore increasing their 
elimination. On the other hand, it may be intrinsic properties of the trisomic MNs, 
such as impaired connectivity, insensitivity to morphogens or trophic factors, or 
altered neurotransmission, that contribute to the hypotonia. 
Overall, we found the PAX6+ population at E12.5 to be significantly 
increased in the Ts65Dn mice. To further investigate the impact of trisomy on this 
population, two subgroups were analyzed. While the ventricular population was 
not altered, the abventricular PAX6+ population was significantly increased in 
trisomic mice compared to euploid controls. This again suggests a dysregulation 
in the SC, specifically in the generation of INs. Unfortunately, we could not 
selectively identify subclasses of PAX6+ spinal INs since appropriate markers are 
not available and IN birth and migration in the ventral horn are not well 
characterized by subtype. However, based on prior literature, all ventral spinal 
INs are known to have been generated and to have reached their final 
destination by E12.5 (Francius et al., 2013), and PAX6+ INs, specifically, are 
shown to have been specified by E11.5 (Panayiotou et al., 2013). Since we are 
unable to distinguish the subpopulations, one limitation of our study is that we 
cannot determine whether the significantly increased PAX6+ abventricular cells 
are still migrating to their terminal locations, or they have reached them at this 
point. Therefore, we could not identify whether the observed defects are due to 
decreased migration or lack of appropriate specification and circuit integration in 
these cells. 
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 We found that the total NKX2.2+ population was not changed at either 
E12.5 or E14.5. To further explore these INs, we assessed the ventricular and 
abventricular NKX2.2+ populations at E12.5 and found a non-significant 25% 
increase in the ventricular population and a significant 18.6% increase in the 
abventricular population in the Ts65Dn ventral SC. The NKX6.1+ IN population 
remained unchanged at both E12.5 and E14.5, however there was a significant 
drop in this population between the two time-points.  
This consistent increase in abventricular INs (seen in both the PAX6+ and 
the NKX2.2+ populations) in Ts65Dn mice suggests a possible dysregulation of 
the excitatory/inhibitory balance within CPGs. V3 INs provide crucial excitatory 
input to CPGs, while the majority of ventral PAX6+ INs provide inhibitory inputs to 
the local circuits (V2a INs are the only other subtype that contribute excitatory 
input). These results, coupled with the altered numbers and distribution of MNs 
and slight changes in OLs, may have profound (amplified) effects postnatally and 
into adulthood, as SC development is highly organized both spatially and 
temporally. Further studies are need to better characterize local network 
dynamics with the ventral horn of the Ts65Dn SC during development and 
postnatally, and their role on locomotive behavior in ambulatory animals.  
Additionally, future studies should be performed to further investigate SC 
development over a larger developmental time window in Ts65Dn mice. Most 
importantly, IHC stains should be carried out at E10.5, as this will elucidate early 
MN development and differentiation. Also, E16.5 SCs should be analyzed to 
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better determine whether the increase in migrating pMN progenitors is due to 
altered neurogenesis, migration, or differentiation in those cells. Furthermore, 
postnatal animal motor behavior assessment is needed in order to establish a 
correlation (or causation) between the observed prenatal deficits, postnatal spinal 
cytoarchitecture and function, and motor function. Later studies should look at 
cellular function, including neurotransmission, dendritic branching and 
innervation in MNs and INs, and maturation and myelin production by OLs. Next, 
cell death in the SC should be analyzed, using activated caspase 3 IHC stains, in 
order to quantify PCD. This will also help to better qualify the change in ISL1+ 
and NKX6.1+ cells from E12.5 to E14.5, as we observed a large decline in cell 
density. In addition, as mentioned above, in vivo neurogenesis assays are 
necessary to explore whether changes in proliferation are occurring in Ts65Dn 
SC, and at which age they arise. Additionally, subcellular analysis would further 
expand our understanding of the effect of trisomy on SC development. RNAseq 
would reveal global gene expression patterns and in situ hybridization would 
identify gene expression changes within individual cells. CHIPseq experiments 
would further elucidate the binding patterns of OLIG2 to its target sequences and 
characterize its function or dysfunction as a transcription factor. Utilizing this 
expanded and rigorous pipeline, we can then assess the effect of Olig2 
upregulation (Lu et al., 2012) or downregulation (Zhou et al., 2001) in transgenic 
mice and can even utilize heterozygous Olig2+/- animals to normalize gene 
dosage in Ts65Dn animals to ameliorate SC deficits in these animals. This 
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essential experiment would identify a definitive and specific causal relationship 
between Olig2 triplication and SC deficits in Ts65Dn mice. 
Though there are many additional experiments needed to answer our 
scientific question of whether and how trisomy 21 affects SC development and 
function, and the correlation between these deficits and motor function in people 
with DS, the work discussed in this thesis lays an expansive foundation for future 
studies. It is a conceptually innovative study, since it is the first to ever analyze 
the SC in the context of DS. Indeed, the data point to dysfunctions in the 
development of multiple spinal cell populations and lay a foundation for future 
discovery. In addition, this work identifies rapid plastic changes in the lumbar SC 
during development which expand on current knowledge in the SC development 
research space.   
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